Jane Street’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-14,500
| Closed | -$165K | – | 11087 |
|
|
2021
Q3 | $165K | Buy |
+14,500
| New | +$212K | ﹤0.01% | 8992 |
|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$338K | – | 5898 |
|
|
2018
Q2 | $338K | Buy |
+5,000
| New | +$280K | ﹤0.01% | 4002 |
|
|
2018
Q1 | – | Sell |
-16,400
| Closed | -$980K | – | 5613 |
|
|
2017
Q4 | $980K | Buy |
16,400
+3,300
| +25% | +$200K | ﹤0.01% | 2369 |
|
|
2017
Q3 | $637K | Buy |
13,100
+5,000
| +62% | +$273K | ﹤0.01% | 2808 |
|
|
2017
Q2 | $426K | Buy |
8,100
+2,700
| +50% | +$126K | ﹤0.01% | 3225 |
|
|
2017
Q1 | $245K | Buy |
+5,400
| New | +$241K | ﹤0.01% | 3661 |
|
|
2016
Q4 | – | Sell |
-20,900
| Closed | -$789K | – | 4780 |
|
|
2016
Q3 | $789K | Buy |
+20,900
| New | +$461K | ﹤0.01% | 2242 |
|
|
2015
Q4 | – | Sell |
-13,100
| Closed | -$232K | – | 4596 |
|
|
2015
Q3 | $232K | Buy |
+13,100
| New | +$237K | ﹤0.01% | 3034 |
|
Jane Street's AERI Position: Q4 2022 in Review
Jane Street sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 13,041 shares — an estimated $197K sold.
Jane Street first reported a position in AERI in Q2 2014 and held it in 16 quarters. The position peaked at $1.81M in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Jane Street reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Jane Street sold 13,041 Aerie Pharmaceuticals shares in Q4 2022, an estimated $197K.
- Jane Street first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Jane Street's Aerie Pharmaceuticals position peaked at $1.81M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.